| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 07/28/2011 | US20110184034 Severe sepsis preventive therapeutic agent |
| 07/28/2011 | US20110184013 Imidazo[1,2-a]Pyridine Compounds As Receptor Tyrosine Kinase Inhibitors |
| 07/28/2011 | US20110184012 Methods and compositions for alleviating stuttering |
| 07/28/2011 | US20110183951 Copper (1) Complex |
| 07/28/2011 | US20110183949 Use of Fulvestrant in the Treatment of Resistant Breast Cancer |
| 07/28/2011 | US20110183923 Peptide antagonists of zonulin and methods for use of the same |
| 07/28/2011 | US20110183922 Peptides that enhance acetylcholinesterase expression |
| 07/28/2011 | US20110183911 Method for improving neurotransmission failure using a novel agent |
| 07/28/2011 | US20110183904 Methods and compositions for altering behavior associated with autism spectrum disorder |
| 07/28/2011 | US20110183416 Method of modulating the proliferation of medullary thyroid carcinoma cells |
| 07/28/2011 | US20110183021 Compositions Containing Purine Nucleosides and Manganese and Their Uses |
| 07/28/2011 | US20110183019 Methods of screening for and treating autism spectrum disorders and compositions for same |
| 07/28/2011 | US20110183001 Compositions and methods for implantation of adipose tissue and adipose tissue products |
| 07/28/2011 | US20110182927 Inhibitors of DNA Immunostimulatory Sequence Activity |
| 07/28/2011 | US20110182911 Use of immobilized antagonists for enhancing growth factor containing bioimplant effectiveness |
| 07/28/2011 | US20110182893 Prevention and treatment of amyloidogenic diseases |
| 07/28/2011 | US20110182879 Novel human transferase family members and uses thereof |
| 07/28/2011 | US20110182868 Human lysosomal proteins from plant cell culture |
| 07/28/2011 | US20110182827 Method and Dosage Form to Confirm Compliant Use of a Bioactive Agent |
| 07/28/2011 | US20110182824 Method and dosage form to confirm compliant use of a bioactive agent |
| 07/28/2011 | US20110182813 Amphiphilic copolymers and compositions containing such polymers |
| 07/28/2011 | US20110182812 Imaging Agents for Detecting Neurological Disorders |
| 07/28/2011 | US20110182811 Nucleotide sequence encoding a modulator of nf-kb |
| 07/28/2011 | US20110182807 Method and Dosage Form to Confirm Compliant Use of a Bioactive Agent |
| 07/28/2011 | CA2792993A1 Special composition for the use thereof as a drug |
| 07/28/2011 | CA2787248A1 Piperazine compound having a pgds inhibitory effect |
| 07/27/2011 | EP2348134A1 RNA interference mediating small RNA molecules |
| 07/27/2011 | EP2348133A1 RNA interference mediating small RNA molecules |
| 07/27/2011 | EP2348047A1 G protein coupled receptor (GPCR) agonists and antagonists and methods of activating and inhibiting GPCR using the same |
| 07/27/2011 | EP2348043A1 APO-2 ligand variants and uses thereof |
| 07/27/2011 | EP2348032A2 6.Alpha.,9.alpha.-difluoro-17.alpha.-'(2-furanylcarboxyl) oxy]-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothiotic acid s-fluoromethyl ester as an anti-inflammatory agent |
| 07/27/2011 | EP2348019A1 1,2-diazetidin-3-one derivative and pharmaceutical agent comprising same |
| 07/27/2011 | EP2347770A2 Process for producing an injectable pharmaceutical preparation |
| 07/27/2011 | EP2347760A2 Use of follistatin for the manufacture of a medicament for the treatment of a non-degenerative nervous system disorder |
| 07/27/2011 | EP2347654A1 Pesticidal formulations |
| 07/27/2011 | EP1682135B1 salt of a tetrahydropyranyl cyclopentyl tetrahydropyridopyridine derivative as CCR2-antagonist |
| 07/27/2011 | EP1598349B1 Novel 2-pyridinecarboxamide derivatives |
| 07/27/2011 | EP1474415B1 1-phenyl-2-heteroaryl-substituted benzimidazole derivatives, the use thereof for producing drugs used in the treatment of immunological diseases |
| 07/27/2011 | EP1443928B1 Treatment of neurodegenerative diseases and cancer of the brain |
| 07/27/2011 | EP1432733B1 Method for identifying gene regulatory peptides |
| 07/27/2011 | EP1351694B2 Promoting cell regeneration and/or cell differentiation with non-metabolizable sugar and a polymeric absorbent |
| 07/27/2011 | EP1278823B1 Clearance of neoplastic cells from mixed cellular compositions using viruses |
| 07/27/2011 | EP1267891B1 Antiadhesive carbohydrates |
| 07/27/2011 | CN1972909B Thio-substituted arylmethanesulfinyl derivatives |
| 07/27/2011 | CN1919204B Method for enhancing nutrient absorption with astragalosides |
| 07/27/2011 | CN1756544B Use of arachidonic acid for normalization of infradian rhythm |
| 07/27/2011 | CN1747744B Regeneration and neogenesis of retinal photoreceptor cell using otx2 gene |
| 07/27/2011 | CN102137930A Double-stranded polynucleotide |
| 07/27/2011 | CN102137853A Glucosyltransferase inhibitor comprising epigallocatechin gallate polymer as active ingredient |
| 07/27/2011 | CN102137682A Anti-hepatitis c virus composition |
| 07/27/2011 | CN102137662A Novel epigallocatechin gallate trimer, and alpha-glucosidase inhibitor comprising epigallocatechin gallate polymer |
| 07/27/2011 | CN102134558A Bacillussubtilis and application thereof in raising Apostichopus japonicus |
| 07/27/2011 | CN102134231A Dipeptidyl peptidase inhibitors |
| 07/27/2011 | CN102134230A Dipeptidyl peptidase inhibitors |
| 07/27/2011 | CN102134229A Dipeptidyl peptidase inhibitors |
| 07/27/2011 | CN102133430A Inductive agent for regeneration of periodontium tissue of temperature sensitivity and preparation method thereof |
| 07/27/2011 | CN102133407A Conjugates of therapeutic or cytotoxic agents and biologically active peptides |
| 07/27/2011 | CN102133392A Water splashing compound preparation for boosting exuviation of shrimps and crabs, hardening shells, preventing diseases and resisting stresses |
| 07/27/2011 | CN102133388A Preparation process of placebo prepared by traditional Chinese medicine |
| 07/27/2011 | CN102133334A Preparation method of compound fructus broussonetiae preparation and application thereof |
| 07/27/2011 | CN101559065B Choerospondias extractive, preparation and application of phenol compound contained in choerospondias extractive |
| 07/27/2011 | CN101538254B Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and therapeutic use |
| 07/27/2011 | CN101496828B Use of total saponin extract of fenugreek |
| 07/27/2011 | CN101394866B Stabilizer for hydrophobic compounds |
| 07/27/2011 | CN101336934B Bear bile buccal tablet and preparation process thereof |
| 07/27/2011 | CN101242849B Promoter of differentiation and keratinization of epidermic cell and functional beverage/food for promotion of keratinization of epidermis |
| 07/27/2011 | CN101054554B Composition for increasing microorganism wall permeability and method for detecting said microorganisms on a membrane |
| 07/26/2011 | US7985842 Anti-IGF-I receptor antibody |
| 07/26/2011 | US7985772 Derivatives of 3,3-diphenylpropylamines |
| 07/26/2011 | US7985760 Piperidinetriol derivatives as inhibitors of glycosyceramid synthase |
| 07/26/2011 | US7985587 Methods of culturing dermal papilla cells |
| 07/26/2011 | US7985435 Triterpene compositions and methods for use thereof |
| 07/26/2011 | CA2603185C Propane-1,3-dione derivative or salt thereof |
| 07/26/2011 | CA2502870C High-molecular weight derivatives of camptothecins |
| 07/26/2011 | CA2484981C 1,3,5-triazine derivatives as ligands for human adenosine-a3 receptors |
| 07/26/2011 | CA2484482C Triple monoamine reuptake inhibitors for the treatment of chronic pain |
| 07/26/2011 | CA2469625C Use of pyridine-2,4-dicarboxylic acid diamides and of pyrimidine-4,6-dicarboxylic acid diamides for selective collagenase inhibition |
| 07/26/2011 | CA2464333C Heteroindanes: a new class of potent cannabimimetic ligands |
| 07/26/2011 | CA2463615C Oxindole hydrazide modulators of protein tyrosine phosphatases (ptps) |
| 07/26/2011 | CA2461571C Muteins of human neutrophil gelatinase-associated lipocalin and related proteins |
| 07/26/2011 | CA2445344C Heterocyclic compound derivatives and medicines |
| 07/26/2011 | CA2438851C Interleukin-18 mutants, their production and use |
| 07/26/2011 | CA2427655C Use of alpha adrenergic receptor agonist to reduce a decrease in neurosensory retinal function following laser therapy for choroidal neovascularization |
| 07/26/2011 | CA2367787C Ligands for metabotropic glutamate receptors |
| 07/26/2011 | CA2334315C Compounds with growth hormone releasing properties |
| 07/26/2011 | CA2268331C Treatment of inner ear hair cells |
| 07/26/2011 | CA2267743C Low dose estrogen interrupted hormone replacement therapy |
| 07/26/2011 | CA2221409C Mch2, an apoptotic cysteine protease, and compositions for making and methods of using the same |
| 07/26/2011 | CA2215350C Transforming growth factor alpha hii |
| 07/21/2011 | WO2011087393A1 Composition of vegetal origin for inhaling the smoke generated upon the combustion thereof |
| 07/21/2011 | WO2011087103A1 Proliferation promoter for mesenchymal stem cells, method for promoting proliferation of mesenchymal stem cells using same, and method for producing same |
| 07/21/2011 | WO2011087102A1 Therapeutic agent for promoting recovery of animal under medical treatment |
| 07/21/2011 | WO2011087066A1 Pharmaceutical for preventing or treating disorders accompanied by ocular angiogenesis and/or elevated ocular vascular permeability |
| 07/21/2011 | WO2011087051A1 Therapeutic agent for atherosclerosis comprising s1p2 receptor antagonist |
| 07/21/2011 | WO2011085474A1 Apparatus and method for delivering honey bee brood pheromone into a hive |
| 07/21/2011 | WO2011085460A1 Flower remedy solution |
| 07/21/2011 | US20110178178 Treatment of Motor Fluctuations |
| 07/21/2011 | US20110178157 Modulation of hsp47 expression |
| 07/21/2011 | US20110178100 Apoptosis inhibitor |
| 07/21/2011 | US20110178079 Guanidine compounds as anesthetics and for treatment of nervous system disorders |